Performance of amide proton transfer imaging to differentiate true progression from therapy-related changes in gliomas and metastases.

Autor: Essed RA; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, De Boelelaan 1117, 1081HV, Amsterdam, Netherlands., Prysiazhniuk Y; Charles University, The Second Faculty of Medicine, Department of Pathophysiology, Prague, Czech Republic., Wamelink IJ; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, De Boelelaan 1117, 1081HV, Amsterdam, Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, De Boelelaan 1117, 1081HV, Amsterdam, Netherlands., Azizova A; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, De Boelelaan 1117, 1081HV, Amsterdam, Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, De Boelelaan 1117, 1081HV, Amsterdam, Netherlands., Keil VC; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, De Boelelaan 1117, 1081HV, Amsterdam, Netherlands. v.c.w.keil@amsterdamumc.nl.; Cancer Center Amsterdam, Imaging and Biomarkers, De Boelelaan 1117, 1081HV, Amsterdam, Netherlands. v.c.w.keil@amsterdamumc.nl.; Amsterdam Neuroscience, Brain Imaging, De Boelelaan 1117, 1081HV, Amsterdam, Netherlands. v.c.w.keil@amsterdamumc.nl.

Publikováno v: European radiology [Eur Radiol] 2024 Aug 12. Date of Electronic Publication: 2024 Aug 12.